Venus Remedies has received another patent grant for a novel antibiotic product VRP008 consisting of a carbapenem and a novel aminoglycoside (NCE entity) from European Patent Office (EPO). Pioneering into antimicrobial resistance research, VMRC is engaged in research for this product from the past 8 years.
For Real Time News & Trading Trends Keep Liking Epic Research Private Limited
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
05:18
Unknown
Posted in:
0 comments:
Post a Comment